Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T06:21:21.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The Publications section received minor wording updates: added clarifications that publications are provided voluntarily and may come from PubMed, and updated the revision from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-23T07:33:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page removed a government funding status notice, a generic operational message unrelated to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-16T05:20:42.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the Study Details page content and layout appear unchanged.
    Difference
    0.1%
    Check dated 2025-11-01T20:32:48.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Summary of changes: added a government operating-status notice and a new 196-week clinical trial publication citation, and updated the software version from v3.1.0 to v3.2.0; the prior version tag v3.1.0 was removed.
    Difference
    2%
    Check dated 2025-10-04T00:45:15.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page updates to Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content.
    Difference
    0.1%
    Check dated 2025-09-26T18:09:48.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.